US Stock · Smart-money analysis

REGN Regeneron Pharmaceuticals, Inc.

QUIET
Price
$673.20
1D
-0.85%
5D
+1.31%
20D
+10.74%
Conviction
37
Buy Score
51
Signal
QUIET
Phase
WATCHING
RVOL
0.3×
RSI
65.5
52w range
$541.00 – $821.11
Sector
Healthcare

REGN (Regeneron Pharmaceuticals, Inc.) is a US stock trading at $673.20, -0.85% on the day. mdvin's smart-money engine places it in the WATCHING operator phase, with a GRINDER accumulation style. Current conviction is 37/100 and the Buy Score is 51. The active signal is QUIET. On fundamentals it looks undervalued (quality grade A, analyst upside +21.60%).

Fundamentals

P/E
16.5
Fwd P/E
12.3
PEG
1.13
ROE
14.5%
Valuation
UNDERVALUED
Quality
A
Analyst upside
+21.60%
Next earnings
2026-07-30
Live deep-dive → Open chart Full screener

Snapshot updated daily; open the live deep-dive for the latest. Educational only — not investment advice.